No paralogue variants have been mapped to residue 1551 for SCN5A.
SCN5A | IFDIVTKQAFDVTIMFLICLNMVTMMVETD>D<QSPEKINILAKINLLFVAIFTGECIVKLAA | 1581 |
SCN1A | VFDFVTRQVFDISIMILICLNMVTMMVETD>D<QSEYVTTILSRINLVFIVLFTGECVLKLIS | 1594 |
SCN2A | VFDFVTKQVFDISIMILICLNMVTMMVETD>D<QSQEMTNILYWINLVFIVLFTGECVLKLIS | 1584 |
SCN3A | VFDFVTRQVFDISIMILICLNMVTMMVETD>D<QGKYMTLVLSRINLVFIVLFTGEFVLKLVS | 1579 |
SCN4A | VYDLVTKQAFDITIMILICLNMVTMMVETD>N<QSQLKVDILYNINMIFIIIFTGECVLKMLA | 1406 |
SCN7A | IFDVVTSQAFNVIVMVLICFQAIAMMIDTD>V<QSLQMSIALYWINSIFVMLYTMECILKLIA | 1304 |
SCN8A | VFDFVTQQAFDIVIMMLICLNMVTMMVETD>T<QSKQMENILYWINLVFVIFFTCECVLKMFA | 1575 |
SCN9A | IFDLVTNQAFDISIMVLICLNMVTMMVEKE>G<QSQHMTEVLYWINVVFIILFTGECVLKLIS | 1557 |
SCN10A | VFDIVTRQAFDITIMVLICLNMITMMVETD>D<QSEEKTKILGKINQFFVAVFTGECVMKMFA | 1529 |
SCN11A | VFDIVTSQIFDIIIISLIILNMISMMAESY>N<QPKAMKSILDHLNWVFVVIFTLECLIKIFA | 1419 |
CACNA1A | MWQFVVSPPFEYTIMAMIALNTIVLMMKFY>G<ASVAYENALRVFNIVFTSLFSLECVLKVMA | 1619 |
CACNA1B | TWTFVVSPPFEYFIMAMIALNTVVLMMKFY>D<APYEYELMLKCLNIVFTSMFSMECVLKIIA | 1525 |
CACNA1C | VWYVVNSTYFEYLMFVLILLNTICLAMQHY>G<QSCLFKIAMNILNMLFTGLFTVEMILKLIA | 1272 |
CACNA1D | FWYVVNSSPFEYMMFVLIMLNTLCLAMQHY>E<QSKMFNDAMDILNMVFTGVFTVEMVLKVIA | 1278 |
CACNA1E | VWHFVVSPSFEYTIMAMIALNTVVLMMKYY>S<APCTYELALKYLNIAFTMVFSLECVLKVIA | 1531 |
CACNA1F | VWATVNSAAFEYLMFLLILLNTVALAMQHY>E<QTAPFNYAMDILNMVFTGLFTIEMVLKIIA | 1243 |
CACNA1G | VHHLCTSHYLDLFITGVIGLNVVTMAMEHY>Q<QPQILDEALKICNYIFTVIFVLESVFKLVA | 1664 |
CACNA1H | IHSLCTSHYLDLFITFIICVNVITMSMEHY>N<QPKSLDEALKYCNYVFTIVFVFEAALKLVA | 1670 |
CACNA1I | IHSMCTSHYLDIFITFIICLNVVTMSLEHY>N<QPTSLETALKYCNYMFTTVFVLEAVLKLVA | 1540 |
CACNA1S | VWYIVTSSYFEYLMFALIMLNTICLGMQHY>N<QSEQMNHISDILNVAFTIIFTLEMILKLMA | 1171 |
cons | > < |
Protein | CDS | Disease Classification | Disease | dbSNP links | Effect Prediction |
---|---|---|---|---|---|
p.D1551N | c.4651G>A | Putative Benign | SIFT: Polyphen: |